Skip to main content
JW SHINYAK CORPORATION logo

JW SHINYAK CORPORATION — Investor Relations & Filings

Ticker · 067290 ISIN · KR7067290007 KO Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2025-12-16 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 067290

About JW SHINYAK CORPORATION

https://www.jw-shinyak.co.kr/shinyak/en…

JW SHINYAK CORPORATION is a pharmaceutical company engaged in the research, development, production, and sale of medicines and medical supplies. The company specializes in treatments for the clinic market, with a notable focus on dermatology and urology. Its product portfolio includes well-known treatments for hair loss, such as Rogaine and Monad, alongside medications for endocrinology disorders, symptoms related to brain vessel defects, and various bacterial infections. In its research and development activities, JW SHINYAK utilizes proprietary foundational technologies like "DC vacuum technology" and "CTP" to advance its pipeline of bio-medicines. The company also manufactures and distributes a range of healthcare products.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 1% confidence The document is a formal notice regarding the setting of a record date for shareholder registry closure, specifically for the purpose of determining shareholders eligible for a bonus issue (free share distribution). This type of corporate action announcement is a standard regulatory filing in the Korean market (KIND/KRX) and does not fit into specific categories like dividend announcements or share buybacks, making it a general regulatory filing.
2025-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement from JW Pharmaceutical regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 45th Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the record date. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2025-12-16 Korean
영업(잠정)실적(공정공시)
Regulatory Filings
2025-11-05 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for JW Shinyak Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains comprehensive financial statements, management discussion and analysis, and operational details, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for JW Shinyak for the second quarter of 2025. It provides key financial highlights such as revenue, operating profit, and net income, comparing them to previous periods. As it is an initial announcement of quarterly financial results containing key highlights, it fits the definition of an Earnings Release (ER). Q2 2025
2025-08-01 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for JW Shinyak Co., Ltd. for the period ending March 31, 2025. It contains detailed financial information, business operations, management discussion, and financial statements, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.